China's CanSinoBIO gets over $2 million from Gates Foundation to develop polio vaccine

2023-10-25 09:23:12

Asian Tech Press (Oct 25) -- Chinese drugmaker CanSinoBIO (688185.SH) announced late Tuesday that it has received over $2 million from the Gates Foundation to develop a polio vaccine.

CanSino Biologics Inc. said in a statement that the company recently signed a project funding agreement with the Bill & Melinda Gates Foundation for recombinant polio vaccine (VLP-IPV).

Under the agreement, the Gates Foundation will provide CanSinoBIO with project grants totaling more than $2 million to support the development of the company's virus-like particle (VLP)-based polio vaccine, VLP-IPV.

CanSinoBIO said that the Gates Foundation will disburse the grants in phases based on the achievement of the project's research and development objectives/milestones and in accordance with an agreed-upon payment schedule.

CanSinoBIO

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tencent Holdings repurchased 3.93 million shares for HK$1.5 billion on January 7
                            2025-01-07

                                    Ireland recorded a 12.8 billion euro fiscal surplus last year due to the "Apple tax" ruling
                            2025-01-07

                                    Ministry of Industry and Information Technology: Promoting technical verification of 10G optical network and artificial intelligence integration
                            2025-01-07

                                    Tencent's major shareholder Prosus reduced its stake in Tencent Holdings from 24.01% to 23.99% on January 6.
                            2025-01-07

                                    U.S. chip stocks rose before the market opened, with Nvidia up 0.6%
                            2025-01-07